Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for evaluating the clinicopathological grade in patients with non-Hodgkin’s lymphoma: a prospective study

Conclusion The dynamic second and third phase could potentially provide good predictors of clinicopathological discrimination, as can the early and delayed phases.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research